Monday November 23 2009 | Biotechnology feed | All feeds
|
|
Iceni BioDiscovery Limited
Download detailed PDF Members: Iceni BioDiscovery Ltd is a product-focused biotechnology company that is developing commercial cell therapies for unmet medical needs. Iceni will initially target diabetes where recent success in transplantation has created a requirement for more human tissue than is available from organ donors. Diabetes is a major and growing disease that would substantially benefit from a new treatment to restore physiological control of blood glucose levels. Nine percent of the UK National Health Service budget is spent on costs related to diabetes and its complications, islet transplantation is the only treatment for diabetes that can avoid these complications. Iceni’s products are based on insulin-producing cells, grown in the laboratory, that will greatly increase the number of patients that can receive a transplant. Products for treating other chronic diseases are in the pipeline. The Intellectual Property being developed by Iceni also opens opportunities for commercial collaborations and out-licensing.
This page has been viewed 458 times since April 2007, the link to the organisation's website has been followed 109 times Recent Search Terms used to find this page: ICENI Marketing Services Ltd. | iceni biodiscovery | ICENI MARKETING SERVICES LIMITED | iceni biodiscovery | biodiscovery and diabetes | ICENI Seed Fund | avlar novartis | iceni biodiscovery ltd | . This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Iceni BioDiscovery Limited | ||||||||||||||||||||||||||||||||||
|